ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. (NDRA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · NDRA · as of Jun 9, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
ENDRA Life Sciences Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
NDRA insider buying and selling by quarter
NDRA insider selling · NDRA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · NDRA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
NDRA executive sell shares · NDRA board member insider trading · NDRA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 2, 2026 | Tokman Alexander Y CEO · Director | Award | 26,921 | — | Form 4 |
| Mar 2, 2026 | Jacroux Richard CFO | Award | 13,461 | — | Form 4 |
| Jan 21, 2026 | DIGIANDOMENICO ANTHONY Director | Award | 60,324 | — | Form 4 |
| Jan 21, 2026 | Harsh Michael Director | Award | 60,324 | — | Form 4 |
| Jan 21, 2026 | Jacroux Richard CFO | Award | 20,000 | — | Form 4 |
| Jan 21, 2026 | Basenese Lou Director | Award | 60,324 | — | Form 4 |
| Jan 21, 2026 | Tokman Alexander Y CEO · Director | Award | 75,000 | — | Form 4 |
| Oct 10, 2025 | DIGIANDOMENICO ANTHONY Director | Award | 70,822 | $500K | Form 4 |
| Jun 11, 2025 | Basenese Lou Director | Award | 5,384 | — | Form 4 |
| Jun 11, 2025 | Harsh Michael Director | Award | 5,384 | — | Form 4 |
| Jun 11, 2025 | DIGIANDOMENICO ANTHONY Director | Award | 5,384 | — | Form 4 |
| Aug 27, 2024 | UBS Group AG 10 percent owner | Purchase | 3,715 | $2K | Form 4 |
| May 18, 2023 | Thornton Michael Milos CTO | Purchase | 15,000 | $25K | Form 4 |
| May 2, 2023 | DIGIANDOMENICO ANTHONY Director | Purchase | 83,333 | $100K | Form 4 |
| Dec 9, 2022 | Thornton Michael Milos CTO | Purchase | 1,500 | $5K | Form 4 |
| Nov 23, 2022 | Tokman Alexander Y Director | Purchase | 10,000 | $2K | Form 4 |
| Aug 22, 2022 | Thornton Michael Milos CTO | Purchase | 20,000 | $5K | Form 4 |
| Aug 22, 2022 | Tokman Alexander Y Director | Purchase | 20,000 | $5K | Form 4 |
| May 26, 2022 | Thornton Michael Milos CTO | Purchase | 25,000 | $5K | Form 4 |
| May 18, 2022 | Thornton Michael Milos CTO | Purchase | 25,000 | $6K | Form 4 |
| May 17, 2022 | Michelon Francois Roger CEO | Purchase | 5,100 | $969 | Form 4 |
| May 16, 2022 | Tokman Alexander Y Director | Purchase | 100,000 | $20K | Form 4 |
| Jan 28, 2021 | Thornton Michael Milos CTO | Award | 22,815 | — | Form 4 |
| Aug 25, 2021 | Basenese Lou Director | Sale | 45,000 | $82K | Form 4 |
| Aug 26, 2021 | Basenese Lou Director | Sale | 5,000 | $9K | Form 4 |
DIGIANDOMENICO ANTHONY
Director
Date
May 2
Shares
83,333
Price
$1.20
Value
$100K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About NDRA insider trading
NDRA insider trades
ENDRA Life Sciences Inc. (NDRA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DIGIANDOMENICO ANTHONY (Director), Tokman Alexander Y (CEO · Director), Jacroux Richard (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. NDRA insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For ENDRA Life Sciences Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
NDRA insider trading · 5 questionsThe insiders of ENDRA Life Sciences Inc. (NDRA) include executives and directors such as DIGIANDOMENICO ANTHONY (Director), Tokman Alexander Y (CEO · Director), Jacroux Richard (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026